Safety of a Non-Viral Plasmid-Encoding Dual Isoforms of Hepatocyte Growth Factor in Critical Limb Ischemia Patients: A Phase I Study

Gene Therapy - United Kingdom
doi 10.1038/gt.2011.21
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety and Efficacy of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Critical Limb Ischemia

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Randomized Controlled Trial of Dual Antiplatelet Therapy in Patients Undergoing Surgery for Critical Limb Ischemia

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2010English

Therapeutic Potential of Hepatocyte Growth Factor Against Cerebral Ischemia (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Characteristics of Physical Activity in Patients With Critical Limb Ischemia

Journal of Physical Therapy Science
Physical TherapySports TherapyRehabilitation
2016English

Limb Salvage in Diabetic Patients With No-Option Critical Limb Ischemia: Outcomes of a Specialized Center Experience

Diabetic Foot and Ankle
Internal MedicinePodiatry
2019English

Increased Incidence of Cancer in Japanese Patients With Critical Limb Ischemia

Annals of Vascular Diseases
2019English

A Cohort Study of Upper Critical Limb Ischemia Secondary to Atherosclerotic Occlusive Disease

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Regenerative Medicine in Critical Limb Ischemia

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

Hepatocyte Growth Factor and Cardiomyopathy in Dialysis Patients

Hypertension
Internal Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy